Craniopharyngioma is a rare, non-cancerous brain tumour that develops near the pituitary gland, a small but vital gland located at the base of the brain. The pituitary gland regulates important hormones, and because of the tumour’s location, craniopharyngiomas can interfere with both hormonal balance and normal brain functions.
These tumours are usually slow-growing, but as they enlarge, they may press on nearby structures such as the optic nerves, hypothalamus, or pituitary gland. This pressure can lead to symptoms like vision problems, frequent headaches, growth or hormonal issues in children, fatigue, excessive thirst, or weight changes.
A common misconception is that all brain tumours are cancerous and rapidly life-threatening. Craniopharyngiomas are not malignant, but they can still cause significant health challenges if left untreated due to their location near critical brain structures.
Understanding craniopharyngioma, its symptoms, and treatment options is essential for patients and families. Modern treatment approaches include surgery (to remove as much of the tumour as safely possible), radiation therapy, and long-term hormone replacement therapy when needed. With proper care, many patients achieve good outcomes and improved quality of life.
People need craniopharyngioma treatment to manage tumour growth, protect vital brain structures, and prevent complications such as vision loss, hormonal imbalances, and severe headaches. Approaches like surgery and radiation therapy aim to remove or control the tumour, restore hormonal balance with replacement therapy when needed, and improve overall quality of life for patients.
The exact causes of craniopharyngiomas are not fully understood, but certain factors are linked to their development:
Symptoms depend on the tumour’s size, growth, and pressure on nearby structures such as the pituitary gland, hypothalamus, or optic nerves. Common symptoms include:
These symptoms lead to treatment when imaging studies confirm the presence of a craniopharyngioma. Because the tumour can press on the pituitary gland, optic nerves, and hypothalamus, early detection is essential. Starting treatment at the right time helps prevent vision loss, correct hormonal imbalances, and protect long-term brain function.
How to Detect Craniopharyngioma?
Early detection of craniopharyngioma allows doctors to plan safe and effective treatment, reducing the risk of serious complications. If this condition is suspected, doctors may recommend the following tests:
Finding craniopharyngioma early and starting the right treatment can help preserve vision, restore hormonal balance, and improve quality of life. If you or a loved one experiences symptoms such as vision problems, frequent headaches, or growth issues in children, myheco can connect you with leading neurosurgery and endocrinology specialists at trusted hospitals.
Some of the world’s most advanced neurosurgery and cancer hospitals offer specialised care for patients with craniopharyngioma, a complex brain tumour requiring precise management. These centres provide comprehensive neurosurgical and multidisciplinary care, including microsurgery, endoscopic surgery, stereotactic radiosurgery, and proton therapy, supported by experienced neurosurgeons, endocrinologists, and multidisciplinary teams. They also offer advanced imaging, hormonal management, and international patient services to ensure continuity of care.
Leading hospitals for craniopharyngioma treatment include:
.png)
.png)
.png)
.png)
These hospitals follow evidence-based treatment protocols, offer access to advanced neurosurgical technologies, and provide coordinated care for international patients seeking treatment for craniopharyngioma.
The average cost of craniopharyngioma treatment ranges from $5,500 to $8,500 in India and from $15,300 to $24,000 in Thailand. The final expense depends on several factors such as the tumour size and location, treatment approach, hospital facilities, and the patient’s overall health. Before checking the detailed table of treatment-wise costs, it is important to understand the main factors that influence craniopharyngioma treatment expenses.
Several elements can impact the overall cost of craniopharyngioma treatment:
Note: India has become a preferred destination for advanced treatment, offering world-class care at a fraction of the international cost. Patients benefit from expert doctors, modern medical technology, and affordable access to high-quality generic medicines, making treatment both effective and economical.
Note: Thailand has established itself as a premium destination, offering world-class hospitals, advanced technology, and internationally trained specialists. Patients choose Thailand not only for its high-quality medical care but also for its holistic approach, combining clinical excellence with exceptional comfort and service standards.
The above figures are approximate and can vary based on the hospital, location, and individual patient requirements. Always consult the healthcare provider for the most accurate and up-to-date pricing.
The currency conversion rates in the table above are based on data from April 2026.
For a detailed cost estimate and guidance on treatment options, patients can contact myheco to connect with leading hospitals.
Studies show that 20% to 40% of patients may experience a recurrence of craniopharyngioma, though the risk is lower when the tumour is fully excised. To monitor this, patients undergo regular MRI or CT scans to detect any signs of regrowth early. Craniopharyngioma patients have a 10-year survival rate of up to 90%. Many patients live well beyond this period, often maintaining a good quality of life.
Leading hospitals adopt a multidisciplinary, patient-focused approach to craniopharyngioma care with accurate diagnosis, tailored treatment, and comprehensive support. Their approach includes:
This integrated approach helps control tumour growth, preserves neurological and hormonal functions, and ensures a better long-term quality of life for patients with craniopharyngioma.
Facing a rare brain tumour like craniopharyngioma can be overwhelming, but myheco supports international patients by connecting them with leading neurosurgeons who specialise in craniopharyngioma care worldwide. Through online consultations, second opinions, and personalised treatment planning, myheco ensures that patients and their families feel informed, supported, and confident before beginning their journey for advanced treatment.
Choosing myheco means expert care, faster access, and comprehensive support throughout your treatment journey.
Note: Myheco does not provide medical advice.
Baby Louis, a young child from Kenya, was battling a recurrent craniopharyngioma that had already caused blindness, lethargy, and severe headaches. He travelled to Max Hospital, Saket, where Dr Arun Saroha performed a complex craniotomy using advanced techniques and technology. The surgery achieved complete tumour removal despite the tumour’s difficult location near vital brain structures. After surgery, Louis’s headaches and physical weakness improved significantly, and his family expressed deep gratitude for the care provided.
✅ Share your medical reports
✅ Receive personalised treatment plans from leading hospitals
✅ Choose the option that suits you best
✅ Let us handle the arrangements
Craniopharyngiomas are benign (non-cancerous) tumours, but they can be challenging due to their location near the pituitary gland and optic nerves. Complete removal or long-term control is possible through surgery or radiosurgery, often combined with hormone therapy. With proper care, most patients maintain a good quality of life.
Treatment depends on tumour size, location, growth rate, and impact on vision or hormones. Options include:
Recovery varies by treatment type. Surgery may require a hospital stay of 1-2 weeks, with additional months for full recovery. Hormone therapy and follow-up imaging continue long-term. Regular check-ups help manage vision, hormonal balance, and overall health.
There is no known way to prevent craniopharyngioma, as the exact causes are unclear. Early detection through MRI scans, vision assessments, and hormone evaluations is crucial to managing the condition before complications arise.
Many patients experience pituitary gland dysfunction after treatment, making hormone replacement therapy necessary. Endocrinologists monitor hormone levels regularly to adjust therapy as needed.
Yes, because the tumour can press on the optic nerves. Early detection and treatment aim to preserve vision, though some patients may have lasting visual changes depending on tumour size and location.
Myheco connects patients with leading neurosurgeons and endocrinologists, arranges online consultations, provides second opinions, offers detailed cost estimates, issues medical visa invitation letters, assists with travel and hospital transfers, and provides multilingual support throughout the treatment journey.
India’s leading hospitals for craniopharyngioma treatment include Manipal Hospital, Apollo Hospital, and Fortis Hospital in Bangalore; Max Hospital, BLK-Max Super Speciality Hospital, Manipal Hospital Dwarka, Medanta – The Medicity, Institute of Brain and Spine (IBS) Hospital, Indraprastha Apollo Hospital, and Fortis Hospital in Delhi; Apollo Proton Cancer Centre (APCC), Apollo Hospital, SIMS Hospital, MGM Healthcare, and Rela Hospital in Chennai; Nanavati Max Super Speciality Hospital, Apollo Hospital, and Fortis Hospital in Mumbai; and Apollo Hospital in Hyderabad. These centres provide advanced microsurgery, endoscopic skull base surgery, stereotactic radiosurgery, precision imaging, and comprehensive neuro-endocrine care, supported by experienced neurosurgeons, endocrinologists, and multidisciplinary teams.
In Thailand, Samitivej Sukhumvit Hospital in Bangkok is internationally recognised for advanced microsurgery, stereotactic radiosurgery, precision imaging, and integrated neuro-endocrine care. The hospital also offers structured international patient services, supporting patients travelling from overseas for craniopharyngioma treatment.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material or content on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website - www.myheco.com
.png)